Editage
Research Solutions English Editing AI Solutions Publication Support Journal Finder Corporate Solutions More

Expert Review of Pharmacoeconomics and Outcomes Research

eISSN: 1744-8379pISSN: 1473-7167

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

Aims and Scope

Expert Review of Pharmacoeconomics & Outcomes Research is a bimonthly peer-reviewed medical journal covering all aspects of pharmacoeconomics. It was established in 2001 and is published by Informa. The editor-in-chief is A. Bottomley (European Organisation for Research and Treatment of Cancer). Less

Key Metrics

CiteScore
3.4
H-Index
60
Impact Factor
< 5
SJR
Q2Health Policy
SNIP
0.9
Time to Publish
time-to-publish View Chart
6  Mo

Journal Specifications

Overview
  • Publisher
    TAYLOR & FRANCIS LTD
  • Language
    English
  • Frequency
    Bi-monthly
General Details
View less
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 13%
4-6 40%
7-9 23%
>9 24%

Topics Covered

Cancer
Economic evaluation
Multiple sclerosis
Acute failure
Etanercept
Quality of life
Drug discovery
Psoriatic arthritis
Cross-sectional study
Breast cancer
Antidepressant
Indirect costs
Nivolumab
Systematic review
Chemotherapy
Rheumatoid arthritis
Total hip arthroplasty
Type 2 diabetes
Cerebral palsy
Pediatric gastroenterology

Recently Published Papers

Year-wise Publication

FAQs

Since when has Expert Review of Pharmacoeconomics and Outcomes Research been publishing? Faqs

The Expert Review of Pharmacoeconomics and Outcomes Research has been publishing since 2001 till date.

How frequently is the Expert Review of Pharmacoeconomics and Outcomes Research published? Faqs

Expert Review of Pharmacoeconomics and Outcomes Research is published Bi-monthly.

What is the H-index. SNIP score, Citescore and SJR of Expert Review of Pharmacoeconomics and Outcomes Research? Faqs

Expert Review of Pharmacoeconomics and Outcomes Research has a H-index score of 60, Citescore of 3.4, SNIP score of 0.9, & SJR of Q2

Who is the publisher of Expert Review of Pharmacoeconomics and Outcomes Research? Faqs

The publisher of Expert Review of Pharmacoeconomics and Outcomes Research is TAYLOR & FRANCIS LTD.

Where can I find a journal's aims and scope of Expert Review of Pharmacoeconomics and Outcomes Research? Faqs

For the Expert Review of Pharmacoeconomics and Outcomes Research's Aims and Scope, please refer to the section above on the page.

How can I view the journal metrics of Expert Review of Pharmacoeconomics and Outcomes Research on editage? Faqs

For the Expert Review of Pharmacoeconomics and Outcomes Research metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Expert Review of Pharmacoeconomics and Outcomes Research? Faqs

The eISSN number is 1744-8379 and pISSN number is 1473-7167 for Expert Review of Pharmacoeconomics and Outcomes Research.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Cancer, Economic evaluation, Multiple sclerosis, Acute failure, Etanercept, Quality of life, Drug discovery, Psoriatic arthritis, Cross-sectional study, Breast cancer, Antidepressant, Indirect costs, Nivolumab, Systematic review, Chemotherapy, Rheumatoid arthritis, Total hip arthroplasty, Type 2 diabetes, Cerebral palsy, Pediatric gastroenterology.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.